Lakewood-Amedex Biotherapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -886 | |||
EBIT | -887 | |||
Net Income | -923 | -744 | -1,907 | -539 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -349 | -422 | -404 | |
Cash | 11 | 236 | 658 | |
Basic Shares | 699 | 13,935 | 13,935 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Net Income | -3,847 | -4,855 | -8,281 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,944 | -5,725 | -6,816 |
Cash | 236 | 681 | 2,529 |
Basic Shares | 13,935 | 13,935 | 13,935 |